Pacific Biosciences Of California | PACB - Net Income

Stock Price
1.71
Daily Change
-0.13 -7.07%
Monthly
-27.54%
Yearly
-7.57%
Q1 Forecast
3.50

Pacific Biosciences Of California reported $-60.72M in Net Income for its fiscal quarter ending in September of 2024.





Net Income Change Date
Agilent USD 434M 98M Sep/2025
Bruker USD 26M 88.4M Dec/2025
Danaher USD 1.2B 289M Dec/2025
General Electric Aerospace USD 2.54B 384M Dec/2025
Illumina USD 334M 184M Dec/2025
Myriad Genetics USD -27.4M 303.1M Sep/2025
Pacific Biosciences Of California USD -60.72M 112.59M Sep/2024
Quidel USD -733M 477.6M Sep/2025
Revvity USD 98.36M 51.71M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Standard Biotools USD -34.69M 1.23M Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Waters USD 225.21M 76.29M Dec/2025